Product Information
TAZAROTENE 0.1% CREAM is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $1.9528 per GM under NDC 51672137303. Its NADAC has been published 462 times since Oct 18, 2017.
FDA first approved this application on Apr 3, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Tazarotene market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672137303
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
TAZAROTENEApproval Type
Generic (ANDA)
FDA Application
ANDA208258FDA Approved
4/3/2017
TE Code
AB
On Market Since
4/3/2017
Pharmacological Classes
Price Statistics
The NADAC for TAZAROTENE 0.1% CREAM has been published 462 times since Oct 18, 2017, and over the history we have for it it has declined 71.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9528 per GM |
|---|---|
| All-time high | $6.7868 (Feb 14, 2018) |
| All-time low | $1.5975 (Nov 20, 2024) |
| 52-week high | $2.0250 |
| 52-week low | $1.8379 |
| Median price | $3.0184 |
| Average price | $3.3515 |
| Largest weekly change | +40.3% (Jun 22, 2022) |
| Weeks tracked | 462 |
| Tracking since | Oct 18, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TAZAROTENE 0.1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for TAZAROTENE 0.1% CREAM, manufactured by Sun Pharmaceutical Industries Inc., is $1.9528 per GM (NDC 51672137303), effective Aug 19, 2026.
How has the price of TAZAROTENE 0.1% CREAM changed over time?
Over the history we have for it, the NADAC for TAZAROTENE 0.1% CREAM has declined 71.2%. It has been tracked across 462 weekly CMS publications since Oct 18, 2017.
What are the highest and lowest recorded NADAC prices for TAZAROTENE 0.1% CREAM?
Since Oct 18, 2017, the NADAC for TAZAROTENE 0.1% CREAM has ranged from a low of $1.5975 (Nov 20, 2024) to a high of $6.7868 (Feb 14, 2018), with a median of $3.0184 per GM.
Are there cheaper alternatives to TAZAROTENE 0.1% CREAM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TAZAROTENE 0.1% CREAM, is $1.8245 per GM — about 7% below TAZAROTENE 0.1% CREAM.
Who manufactures TAZAROTENE 0.1% CREAM?
TAZAROTENE 0.1% CREAM (NDC 51672137303) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.